Amit A Kulkarni – Projects and Grants — Experts@Minnesota

View Scopus Profile

Research activity per year

2 Finished
3 Active

5 results

Active
A randomized phase II trial of adjuvant Pembrolizumab versus observation following curative resection forstage I non-small cell lung cancer (NSCLC) with primary tumors between 1-4 cm: Big Ten Cancer ResearchConsortium BTCRC-LUN18-153
Kulkarni, A. A.
BIG TEN CANCER RESEARCH CONSORTIUM
6/29/20 → 6/30/26
Project: Research project
A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors wit KRAS G12C Mutation
Kulkarni, A. A. & Patel, M. R.
MIRATI THERAPEUTICS, INC.
3/26/20 → 3/31/25
Project: Research project
A Phase II Trial of Restorative Microbiota Therapy (RMT) in Combination with Durvalumab (MEDI4736) orDurvalumab (MEDI4736) + Chemotherapy in Untreated Patients with Advanced or MetastaticAdenocarcinoma Non-Small Cell Lung Cancer
Kulkarni, A. A.
ASTRAZENECA
9/16/19 → 9/30/25
Project: Research project
Finished
Association of gut microbiome and treatment outcomes with enzalutamide and darolutamide in castrate resistant prostate cancer
Kulkarni, A. A., Prizment, A. E. & Staley, C.
BRIGHAM AND WOMEN'S HOSPITAL, NATIONAL INSTITUTES OF HEALTH (NIH)
9/1/21 → 2/28/23
Project: Research project
Risk factors and predictors of severe COVID-19 and mortality in patients with lung cancer
Kulkarni, A. A.
INTL ASSOC FOR THE STUDY OF LUNG CANCER
3/1/21 → 11/30/22
Project: Research project

Your message has successfully been sent.

Your message was not sent due to an error.